MA10-MA50 Bull Crossover Stocks (Dec.12)

NASDAQ: CTIC (Cell Therapeutics)

NASDAQ: CTIC (Cell Therapeutics) has closed at $2.4, its traded Volume was 1481.59K shares, CTIC opened the Day at $2.37, it made an intraday Low of $2.34, and an intraday High of $2.44. CTIC (Cell Therapeutics) 52-week High is $4.25, 52-week Low is: $1.69, it has supports at $2.21 and $2, resistances at $2.55 and $2.97. CTIC’s earning is $-0.3 per share, Next quarter estimated EPS is $-0.15, current year estimated EPS is $-0.59. Its PE ratio is -8. Overall, this stock is rated Neutral today.

NYSE: DHT (Dht Holdings)

NYSE: DHT (Dht Holdings) has closed at $6.64, its traded Volume was 4917.73K shares, DHT opened the Day at $6.45, it made an intraday Low of $6.43, and an intraday High of $6.93. DHT (Dht Holdings) 52-week High is $8.497, 52-week Low is: $5.181, it has supports at $5.84 and $5.18, resistances at $6.92 and $8.08. DHT’s earning is $-0.07 per share, Next quarter estimated EPS is $0.13, current year estimated EPS is $-0.14. Its PE ratio is -95. Overall, this stock is rated STRONG BUY today.

NYSE: FRO (Frontline Ltd)

NYSE: FRO (Frontline Ltd) has closed at $2.25, its traded Volume was 7042.76K shares, FRO opened the Day at $2.03, it made an intraday Low of $1.88, and an intraday High of $2.34. FRO (Frontline Ltd) 52-week High is $5.18, 52-week Low is: $1.18, it has supports at $1.62 and $1.19, resistances at $2.33 and $2.72. FRO’s earning is $-1.74 per share, Next quarter estimated EPS is $-0.09, current year estimated EPS is $-0.54. Its PE ratio is -1. Overall, this stock is rated BUY today.

NYSE: GPT (Gramercy Capital Corp.)

NYSE: GPT (Gramercy Capital Corp.) has closed at $6.51, its traded Volume was 6920.18K shares, GPT opened the Day at $6.4, it made an intraday Low of $6.35, and an intraday High of $6.63. GPT (Gramercy Capital Corp.) 52-week High is $6.63, 52-week Low is: $4.884, it has supports at $5.99 and $5.6, resistances at $6.63 and $7.74. GPT’s earning is $0.49 per share, Next quarter estimated EPS is $-0.02, current year estimated EPS is $0.49. Its PE ratio is 13. Overall, this stock is rated BUY today.

AMEX: NAVB (Navidea Biopharmaceuticals Inc.)

AMEX: NAVB (Navidea Biopharmaceuticals Inc.) has closed at $1.49, its traded Volume was 3435.14K shares, NAVB opened the Day at $1.27, it made an intraday Low of $1.27, and an intraday High of $1.51. NAVB (Navidea Biopharmaceuticals Inc.) 52-week High is $2.25, 52-week Low is: $0.97, it has supports at $1.17 and $0.97, resistances at $1.5 and $1.75. NAVB’s earning is $-0.29 per share, Next quarter estimated EPS is $-0.05, current year estimated EPS is $-0.24. Its PE ratio is -5. Overall, this stock is rated BUY today.